Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ullensaker Legesenter AS
AS
Active
Org 932542366
Ringvegen 23, 2066
Jessheim
General medical practice activities
·
NACE 8621
Est. 2023 · 2 years old
0 employees
Monitor
Share
Norway
/
Companies
/
General medical practice activities
/
Ullensaker Legesenter AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
2M
2M
1M
1M
0M
2023: 0M
0M
2023
2024: 2M
2M
2024
2025: 2M (0% vs 2024)
2M
0%
2025
EBITDA
NOK millions
0M
0M
0M
-1M
-1M
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
NOK thousands
Item
2025
2024
2023
Revenue
1 820
1 779
0
Staff expenses
−649
−585
−0
EBITDA
147
60
−58
Depreciation & amort.
−42
−41
−9
EBIT
105
18
−67
Net financials
−3
−3
0
Profit before tax
102
16
−67
Tax
11
−0
−0
Net profit
91
16
−67
Balance sheet
NOK thousands
Item
2025
2024
2023
Total assets
655
189
362
Equity
69
−22
−37
Long-term debt
2
0
0
Short-term debt
585
211
400
Total debt
587
211
400
Financial ratios
5-year trend
EBITDA margin
8,1 %
This company
15,8 %
Market median
This company
Market median
49% below market
2023
2025
Equity ratio
10,5 %
This company
38,2 %
Market median
This company
Market median
73% below market
2023
2025
Return on equity
131,6 %
This company
18,4 %
Market median
This company
Market median
615% above market
2023
2025
Net profit margin
5,0 %
This company
8,1 %
Market median
This company
Market median
38% below market
2023
2025
Asset turnover
2,78×
This company
1,12×
Market median
This company
Market median
148% above market
2023
2025
Debt / equity
8,51×
This company
0,62×
Market median
This company
Market median
>999% above market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
More on Ullensaker Legesenter AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
